Loading…
In person · Pittsburgh · PA · United States
Research provider: Pitt+Me
Are you a liver transplant candidate? You may be eligible for a research study to evaluate a new way to prevent or decrease complications of a common viral infection Cytomegalovirus (CMV) after liver transplant. This research is studying an experimental CMV vaccine (Triplex) that is not yet approved by the Food and Drug Administration (FDA). Compensation is provided.
Receive 2 intramuscular injections of the study injection (Triplex or Placebo), approximately 28 days apart Fill out a daily symptom survey for 7 days after each study injection Have blood draws on the days you receive the study injection and for up to 7 additional times: 4 prior to transplant, and 3 after transplant if applicable Be followed for up to 18 months (up to 12 months after getting the study injection, and up to 6 months after liver transplant if you receive a transplant within 1 year)
Are you a liver transplant candidate? You may be eligible for a research study to evaluate a new way to prevent or decrease complications of a common viral infection Cytomegalovirus (CMV) after liver transplant. This research is studying an experimental CMV vaccine (Triplex) that is not yet approved by the Food and Drug Administration (FDA). Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.